Resource Anti-nucleocapsid antibodies following SARS-CoV-2 infection in the blinded phase of the mRNA-1273 Covid-19 vaccine efficacy clinical trial Ludwig Van - May 2, 2022 0 https://www.medrxiv.org/content/10.1101/2022.04.18.22271936v1